This version of the page http://www.darnitsa.ua/en/researches (172.67.132.146) stored by archive.org.ua. It represents a snapshot of the page as of 2023-09-19. The original page over time could change.
Researches - Darnitsa Pharmaceutical Company

Font

Aa Aa Aa

Background color

A A

Site version

Color Black and white
Укр Рус Eng

The Information in this section is intended for healthcare professionals only.

Please confirm that you are a healthcare professional.

Yes No

Cookies

This site uses cookies for site interaction analysis with a purpose of service quality enhancing and uninterrupted site work. More details in Cookies Policy
Accept

Research

The research presented on this page is not an exhaustive list of the company's research
05 June 2023

Summary of bioequivalence study for Darfen, coated tablets (ibuprofen)

17 February 2023

Summary of therapeutic equivalence study results for Darfen Gel, gel (ibuprofen and levomenthol)

17 February 2023

Summary of therapeutic equivalence study results for Darfen Gel, gel (ibuprofen and levomenthol)

25 January 2023

Summary of bioequivalence study for EFEZ, 25 mg eplerenone film-coated tablets; 50 mg eplerenone film-coated tablets

24 January 2023

Summary of bioequivalence study for TIARA SOLO®, 80 mg valsartan film-coated tablets; 160 mg valsartan film-coated tablets

20 January 2023

Summary of bioequivalence study for PERINDOPRES DUO, 4 mg perindopril tert-butylamine / 1.25 mg indapamide tablets; 8 mg perindopril tert-butylamine / 2.5 mg indapamide tablets

Specialized edition for medical institutions and doctors.